Larta's Life Science Advisory Committee

Larta Institute is proud of the partnerships we've built with many of the following leaders in the health sciences. These partners are committed to exploring new business opportunities and collaborations with the emerging companies involved in Larta's NIH-CAP and other life science initiatives.

G. Steven Burrill, CEO, Burrill & Company

Victor Hwang, T2 Venture Capital

Rainer Fuchs, Vice President, Biogen Idec Innovation Incubator, Biogen Idec, Inc.

Paul M. Grand, Director, RCT BioVentures, Research Corporation Technologies, Inc.

Bruce Halpryn, Sr. Director, New Business Development & Global Leader, Technical Due Dillegence, P&G Pharmaceuticals

Kinney Horn, Business Development, Genentech

Don A. Madren, Associate Director, Strategic Alliances, Pfizer

Graeme R. Martin, CEO, Takeda Research Investment Inc.

Jeff Kogl, Sr. Director, Ventures Program, Medtronic

Bruce Pratt, Vice President, Science Development, Genzyme Corporation

Kimberly Rogers, VP, Technology Assessment, Allergan

Dr. James M. Schaeffer, Executive Director of Worldwide Licensing and External Research, Merck & Co., Inc.

Joseph Smith, Vice President, Emerging Technologies, Johnson & Johnson 

Ben Verwer, Manager, Corporate Strategy & Development, BD Ventures

Boris Nikolic, Sr. Program Officer, Global Health & Discovery, Bill & Melinda Gates Foundation